• Call(WhatsApp Us)

    +8615360806100
  • Email Us

    cherry@laeyo.com
  • 广州市花都区花山镇华辉路18号

    微观化妆品创意产业园E栋整栋

Unscented vs Fragrance-Free Moisturizers: What Should U.S. Sensitive-Skin Brands Clarify?

“Fragrance-free” and “unscented” look interchangeable on a spec sheet, but in U.S. body care they are two different claims with two different evidence trails. A moisturizer can be labeled unscented and still contain a…

Category: Body Care Sourcing Guides • Author: laeyo • Published: 2026-11-15 • Views: 23

“Fragrance-free” and “unscented” look interchangeable on a spec sheet, but in U.S. body care they are two different claims with two different evidence trails. A moisturizer can be labeled unscented and still contain a masking fragrance; a formula can contain no added parfum and still carry aromatic essential oils, botanical extracts, or a functional ingredient with a strong base odor. Before you brief a manufacturer or approve artwork, clarify which claim you are actually making, who signs off on it, and which documents prove it. This guide gives sourcing teams a working checklist for that decision.

1. TL;DR: the 60-second version

  • What triggers the risk: U.S. body care claims around scent — “fragrance-free,” “unscented,” “natural fragrance,” plus adjacents like “hypoallergenic” and “dermatologist tested” — are interpreted differently by different retailers and by consumers. The word “fragrance-free” is not self-defining, and it is not established simply because no parfum appears in the formula.
  • Decide first (highest leverage): (1) which single term you will use per SKU and how your brand standard defines it; (2) whether the formula’s inherent base odor is acceptable to your target consumer; (3) who formally signs the claim — regulatory plus brand, not sales alone.
  • Fastest safe path: Lock claim wording and full raw-material disclosure at the brief stage, before prototypes. Scent-masking strategy, texture, and cost optimization can be tuned later; claim wording cannot be retrofitted cheaply after stability and artwork are done.
  • Request immediately (top five): (1) finished-goods INCI mapped to every raw material with function; (2) a fragrance declaration per raw material covering Parfum, essential oils, masking agents, and inherently odorous actives; (3) stability and preservative-efficacy protocols with interim data; (4) the patch/dermatologist test protocol and report, including the finished product code tested; (5) the label artwork review and sign-off record.
  • Do not accept: a verbal “there’s no fragrance in it,” a claim substantiation memo with no formula version attached, or a raw-material study used to support a finished-product claim.

Informational only, not legal advice. Claim acceptability depends on your formula, your label, your retailer, and your market; confirm with qualified regulatory counsel.

2. Decision tree: where does your project sit?

START HERE → Do you need the claim on pack, or only in marketing copy?
  ├─ On pack → go to CLAIM DEFINITION below; nothing else starts first.
  └─ Marketing only → still define the term in your brand standard, then proceed.

CLAIM DEFINITION
  If you want "fragrance-free" → require a full raw-material scent screen (Parfum, essential oils,
     masking/odor-masking agents, odorous functional actives) BEFORE building the brief.
  If you want "unscented" → confirm whether a masking fragrance is permitted, and set an odor
     intensity acceptance criterion with a sensory panel.
  If you want "natural fragrance" → treat it as a fragrance for disclosure purposes and map
     allergen declaration requirements.

FORMULA
  If the base has a noticeable odor the consumer may reject → decide now: reformulate, mask, or
     change the claim. Do not wait for consumer complaints.
  If the formula is water-based and thin → start packaging compatibility early; viscosity drift and
     pump mismatch are common.

BOUNDARY CASES → escalate before proceeding
  If any claim implies treating a condition (redness relief, eczema, "repairs barrier") → regulatory
     pathway decision needed; do not treat as ordinary cosmetic copy.
  If you also sell in the EU or Canada → individual fragrance allergen declaration thresholds apply;
     "Parfum" alone may be insufficient.
  If you plan "hypoallergenic" or "clinically proven" → require a finished-product study design
     reviewed by regulatory, not a single patch test.

3. What to ask your manufacturer: the minimum request pack

Send this as a single written request. Each item below is written so the reply is a deliverable, not an opinion.

A. Compliance, filings, and claim governance

  • Request: A written definition of the scent claim term you will use, mapped to your target market and to each retailer’s ingredient/claim requirements.
    Evidence: Signed claim matrix (term, definition, market, retailer, approved/rejected, sign-off date).
    Owner: Buyer + Manufacturer.
    Acceptance criteria: One page, one claim term per SKU, dated signature from regulatory and brand.
  • Request: Complete raw-material mapping of the finished formula, with the function of each material stated.
    Evidence: Finished-goods INCI cross-referenced to a raw-material list with supplier names and stated functions.
    Owner: Manufacturer.
    Acceptance criteria: 100% of raw materials mapped; zero entries marked “proprietary fragrance” or “q.s.” without a supplier declaration behind them.
  • Request: A fragrance-related declaration for every raw material, not just for the compound labeled as fragrance.
    Evidence: Supplier statement per material covering: added Parfum/fragrance (yes/no), aromatic essential oils (yes/no), masking or odor-neutralizing function (yes/no), and inherent strong odor (description).
    Owner: Manufacturer + raw-material suppliers.
    Acceptance criteria: A completed declaration form for every material, including preservatives, emulsifiers, and actives.
  • Request: Confirmation of which claims will be made on pack versus in digital copy, and which require a regulatory pathway decision.
    Evidence: Claim inventory with a category flag (cosmetic claim / needs substantiation / needs regulatory review).
    Owner: Buyer + Manufacturer.
    Acceptance criteria: No claim reaches artwork without a category flag and named approver.

B. Testing and substantiation

  • Request: Stability protocol and interim results, including an odor and color assessment at each pull point.
    Evidence: Protocol with conditions and time points, plus interim reports; final report at completion.
    Owner: Manufacturer / Lab.
    Acceptance criteria: Accelerated data covering at least 12 weeks with defined pass limits for pH, viscosity, odor, and color; a written commitment to real-time data through the declared shelf life.
  • Request: Preservative efficacy (challenge) testing and finished-product micro results.
    Evidence: PET report and per-batch microbiological COA.
    Owner: Lab.
    Acceptance criteria: Pass against the stated method and criteria, with the exact formula version and preservative level named in the report.
  • Request: Patch test or HRIPT protocol, if you intend to support a sensitive-skin or hypoallergenic positioning.
    Evidence: Protocol with subject count, inclusion/exclusion criteria, dermatologist supervision, and observed reactions, including stinging and redness endpoints.
    Owner: Lab / third-party CRO.
    Acceptance criteria: Report names the finished product code tested, states the dermatologist’s role, and reports reaction incidence numerically — not as “passed.”
  • Request: If you plan “clinically proven” or “dermatologist tested,” the study design and report for the finished product.
    Evidence: Study protocol and final report identifying study type, finished product, subjects, endpoints, and results.
    Owner: Manufacturer / CRO.
    Acceptance criteria: The report is for the finished formulation and batch family you will ship; a raw-material study is not accepted as a substitute.
  • Request: A sensory odor evaluation for the intended claim.
    Evidence: Blind panel report with an odor intensity scale, evaluated at release and at an aged time point.
    Owner: Manufacturer.
    Acceptance criteria: Defined scale, defined panel size, results reported at T0 and at least one aged point (for example 8 or 12 weeks).

C. Labeling and claims guardrails

  • Request: Artwork review against the final formula version.
    Evidence: Redlined artwork, corrected file, and a dated sign-off record.
    Owner: Buyer + Manufacturer.
    Acceptance criteria: INCI order, allergen statements, and net content verified against the locked formula; no claim line appears without a matching entry in the claim matrix.
  • Request: Review of every scent-adjacent term on pack and in copy: unscented, fragrance-free, natural fragrance, clean, natural, chemical-free.
    Evidence: Claim-by-claim review memo with a decision and rationale for each term.
    Owner: Manufacturer regulatory + Buyer.
    Acceptance criteria: Each term is either supported by a named document or removed; “chemical-free” and “natural means safer” implications are removed.
  • Request: Clarification of what the moisturizing claim refers to (body, hands, face, or scalp and hair).
    Evidence: Written claim scope statement tied to the application area and the test conditions.
    Owner: Buyer + Manufacturer.
    Acceptance criteria: The claim statement names the application site; consumer expectation and test conditions match that site.

D. QA, traceability, and audit readiness

  • Request: Batch record template and a sample COA.
    Evidence: Blank batch record plus one completed example, and a COA showing specification, result, batch number, and manufacture/expiry dates.
    Owner: Manufacturer.
    Acceptance criteria: COA values match the specification sheet line by line; batch number is traceable to the batch record.
  • Request: Current SDS per shipping market and GMP evidence.
    Evidence: SDS in the required language(s) and a GMP certificate or audit report (for example ISO 22716).
    Owner: Manufacturer.
    Acceptance criteria: Documents are current, dated, and cover the site that will actually produce your batch.
  • Request: A written change-control clause covering raw materials, suppliers, and process.
    Evidence: Signed quality agreement with notification windows.
    Owner: Buyer + Manufacturer.
    Acceptance criteria: Advance written notice before any change that could affect odor, pH, viscosity, or the scent claim; re-testing triggered by defined change types.
  • Request: Retained-sample and complaint-handling procedure.
    Evidence: Procedure document plus a sample complaint trend report.
    Owner: Manufacturer.
    Acceptance criteria: Retention defined relative to expiry; complaint categories include odor deviation and irritation reports.

Evidence pack summary (minimum deliverables)

  • Signed claim matrix defining “unscented” or “fragrance-free” for each SKU.
  • Finished-goods INCI mapped to every raw material with stated function.
  • Per-material fragrance declaration (Parfum, essential oils, masking function, inherent odor).
  • Allergen declaration statement consistent with the target market’s disclosure rules.
  • Stability protocol with interim and final reports, including odor and color checks.
  • Preservative efficacy test report and per-batch microbiological COA.
  • Patch test or HRIPT report naming the finished product code and dermatologist role.
  • Finished-product clinical or dermatologist-tested report, if that claim is used.
  • Packaging compatibility report (fill-and-store, pump function, label adhesion).
  • Approved artwork with redlines and dated sign-off.
  • Batch record template, sample COA, current SDS, GMP certificate.
  • Signed quality agreement covering change control and notification windows.

4. Realistic timeline, aligned to the U.S. market

Two paths. The compressed path runs independent workstreams in parallel and accepts a standard platform base and standard packaging. It does not shorten microbiological or stability windows.

Phase Buyer action Manufacturer action Evidence output Fastest safe path Standard path
Claim and formula brief Pick one scent term per SKU; state retailer and target consumer Screen raw materials for fragrance-related content; flag conflicts Signed claim matrix; declaration forms 1 week 1–2 weeks
Prototype and odor screening Approve odor intensity acceptance criterion Build 2–3 prototypes; run internal panel Prototype specs; sensory notes 2–3 weeks 3–4 weeks
Packaging lock Confirm bottle, pump, closure, label stock Order components; confirm liner and gasket materials Component spec sheets; supplier declarations 2–3 weeks (stock components only) 4–6 weeks (custom tooling)
Stability (accelerated) Approve pass/fail limits in writing Start accelerated study at T0 with odor and color pulls Protocol; interim reports; final report 12 weeks minimum, run in parallel 12 weeks accelerated plus 12 months real time
Micro and preservative efficacy Confirm method and acceptance criteria Run challenge test and finished-product micro PET report; per-batch COA 4–6 weeks, run in parallel 6–8 weeks
Packaging compatibility Approve the fill-and-store test plan Fill and store units; check pump function, leakage, label adhesion, odor transfer Compatibility report with photos and closure torque data 4 weeks, run in parallel 8 weeks
Patch / dermatologist testing Confirm protocol and subject profile Commission third-party study on finished product Signed study report with reaction incidence 4–6 weeks (do not compress below protocol) 6–8 weeks
Label review and claims sign-off Circulate artwork with the claim matrix attached Regulatory review; return redlines Approved artwork; dated sign-off record 1–2 weeks 2–3 weeks (includes retailer review)
Pilot run and scale-up check Approve pilot batch against lab standard Run pilot; compare pH, viscosity, odor, fill weight Pilot batch record; QC comparison table 2 weeks 3–4 weeks
Final documentation handoff Verify pack completeness against the evidence list Issue COA, SDS, stability and micro reports, GMP certificate Complete evidence pack 1 week 1–2 weeks

What may be compressed: prototype rounds (by locking the platform base early), packaging lead time (by using stock components), label review cycles (by submitting a complete claim matrix the first time). What may not be compressed: challenge test duration, the accelerated stability window, patch test observation periods, and packaging fill-and-store time — each of these produces data that cannot be inferred.

5. Common failure modes: symptom, cause, prevention, evidence

5.1 “Fragrance-free” claim challenged after launch

  • Symptom: A retailer or a consumer review flags that the product contains an aromatic ingredient while the pack says fragrance-free.
  • Root cause: The claim was based only on the absence of a material labeled parfum; essential oils, botanical extracts, or masking agents were never screened.
  • Prevention: Claim only after full ingredient and market review — every raw material declared for fragrance function before the claim is written.
  • What to request from factory (evidence): Per-material fragrance declaration form; signed claim matrix referencing the locked formula version.

5.2 Packaging compatibility failure: odor transfer and pump mismatch

  • Symptom: An unscented lotion picks up a plastic or floral note after two months in the bottle; the pump strokes unevenly or the bottle weeps at the shoulder; labels lift at the edges in humid storage.
  • Root cause: No fill-and-store compatibility study. Aromatic components interact with polyolefin walls and cap liners, adhesive chemistry is mismatched to the bottle surface, and viscosity drift changes pump priming behavior.
  • Prevention: Run a compatibility study on the actual container, closure, and label stock before the pilot, with an odor check by a blind panel at T0 and after storage.
  • What to request from factory (evidence): Compatibility report covering leakage, closure torque, pump delivery rate, label adhesion after humidity exposure, and odor panel results on stored units; component spec sheets including liner and gasket material.

5.3 Documentation failure: mismatched INCI and missing reports

  • Symptom: The COA references a formula version that no longer matches the label; stability or micro reports cannot be located at the audit; the INCI order on pack differs from the specification sheet.
  • Root cause: No version control linking formula, specification, artwork, and test reports. Documents are produced per request rather than maintained as a set.
  • Prevention: Tie every document to a formula and artwork revision number, and make the evidence pack a release condition rather than an afterthought.
  • What to request from factory (evidence): Controlled document index with revision numbers; sample COA; stability and micro reports naming the formula version; approved artwork with redlines and sign-off.

5.4 Base odor rejected by consumers post-launch

  • Symptom: Reviews describe the product as “smelling like crayons” or “smelling like nothing but chemicals,” despite an unscented claim.
  • Root cause: The claim was defined chemically, not sensorially. No odor acceptance criterion existed, and no one evaluated the aged product.
  • Prevention: Set an odor intensity scale and acceptance range at the brief stage, and evaluate aged samples, not only fresh lab batches.
  • What to request from factory (evidence): Blind sensory panel report with scale definition and results at T0 plus an aged point.

5.5 Late reformulation to remove a masking agent

  • Symptom: Three weeks before print, someone discovers the “unscented” formula contains an odor-masking compound and requests removal; the project restarts stability.
  • Root cause: The distinction between “no added fragrance” and “no fragrance at all” was never clarified with the buyer.
  • Prevention: Ask the buyer explicitly whether they want a genuinely fragrance-free formula or simply a product without obvious scent, then screen the formula for parfum, essential oils, masking agents, and inherent base odor before prototyping.
  • What to request from factory (evidence): Written clarification record from the buyer, plus the completed per-material declaration set.

5.6 “Hypoallergenic” supported by a single patch test

  • Symptom: Retailer rejects the substantiation file; the claim is removed from pack late in the process.
  • Root cause: One patch test was treated as automatic proof of hypoallergenicity without considering market expectations or the full evidence set.
  • Prevention: Decide the claim before testing, then design a protocol that matches the claim and the market; align the evidence package to the specific term.
  • What to request from factory (evidence): Study protocol reviewed against the intended claim; final report with subject counts, dermatologist role, and reaction incidence.

5.7 Finished-product claim supported by a raw-material study

  • Symptom: “Clinically proven” appears on pack, but the study cited tested an ingredient, not the formulation.
  • Root cause: Documentation was assembled from supplier marketing files rather than from testing on the finished product.
  • Prevention: Require the report to name the finished product code, batch family, subjects, and endpoints; reject ingredient-level substitution.
  • What to request from factory (evidence): Final clinical report for the finished formulation, with the study type and results stated explicitly.

5.8 pH and irritation complaints on a “gentle” body wash or lotion

  • Symptom: Consumers report stinging or tightness; the product tests outside the intended pH range at release.
  • Root cause: The pH window was never specified as a release specification, or the preservative system shifted pH during scale-up.
  • Prevention: Write pH into the specification with a tolerance, verify it at pilot scale, and keep the base formulation simple — basic moisturizing systems without irritant actives are easier to defend for sensitive-skin positioning.
  • What to request from factory (evidence): Specification sheet with pH range, pilot and production QC data, and stability pH trend across pull points.

6. Copy-paste checklist and summary table

6.1 Email-ready checklist for your supplier

Share the locked formula version number and target launch date.
Confirm which claim term applies per SKU: unscented or fragrance-free.
Provide a per-material declaration covering Parfum, essential oils, masking agents, and inherent odor.
Attach supplier statements for every aromatic or odorous raw material.
Clarify whether a masking fragrance is permitted in this formula.
Confirm the pH specification and tolerance for the finished product.
Provide the stability protocol with pull points and odor/color checks.
Attach interim stability data if the study has started.
Provide the preservative efficacy test protocol and report.
Attach a sample finished-product COA with batch traceability.
Confirm the packaging components, liner, and gasket materials.
Test fill-and-store compatibility with the actual bottle, pump, and label stock.
Report pump delivery rate, leakage, closure torque, and label adhesion after storage.
Run a blind odor panel on fresh and aged units and share the results.
Provide the patch test or HRIPT protocol for review before dosing.
Confirm the dermatologist's role in the study and the finished product code tested.
Attach the label artwork with redlines for regulatory review.
Map every on-pack claim to a supporting document in the claim matrix.
Confirm the moisturizing claim scope: body, hands, face, or scalp.
Provide current SDS in the required market language.
Attach the GMP certificate or audit report for the producing site.
Provide the batch record template and retained-sample procedure.
Confirm change-control notification windows in a signed quality agreement.
Lock artwork only after regulatory and brand sign-off are recorded.
Deliver the full evidence pack before the first production batch releases.

6.2 Summary table: levers, red lines, and evidence

Lever / Decision Primary impact What to do (specific) Do NOT cut (red line) Evidence needed (request) Expected timeline effect
Claim term selection Claim defensibility; retailer acceptance Choose one term per SKU and define it in a signed claim matrix before the brief Full raw-material scent screen including masking agents and essential oils Signed claim matrix tied to formula version Saves 4–6 weeks if done pre-brief; adds them if done post-stability
Fragrance-related raw material screen Substantiation of both scent claims Obtain a declaration for every material, not only the fragrance compound No material accepted without a completed declaration Per-material declaration forms from suppliers Runs in parallel with prototyping; no added time if started at brief
Odor acceptance criterion Consumer satisfaction; review risk Define an odor intensity scale and acceptance range, then test fresh and aged units Blind sensory panel at T0 and at least one aged point Sensory panel report with scale definition Adds 2–3 weeks; prevents a late reformulation that costs more
Preservative and micro testing Product safety and release Run challenge testing plus finished-product micro per batch Preservative efficacy test on the finished formula PET report and per-batch microbiological COA 4–6 weeks; cannot be shortened by parallelization
Stability program Shelf life and claim support Set pass/fail limits in writing before the study starts, including odor and color Accelerated data through at least 12 weeks plus real-time commitment Stability protocol, interim reports, final report 12 weeks minimum; start at prototype approval, not at pilot
Packaging compatibility Odor integrity, leakage, label performance Fill and store the actual container, pump, and label stock before pilot Odor panel on stored units plus pump delivery and adhesion checks Compatibility report with photos and test data 4 weeks in parallel; 8 weeks if components change
Label and claims review Prevents print-stage rework Submit artwork together with the claim matrix in one review cycle Dated regulatory sign-off before print release Redlined artwork plus sign-off record 1–2 weeks with a complete submission; 4+ with piecemeal review
Sensitive-skin substantiation Supports hypoallergenic or gentle positioning Decide the claim first, then design the protocol to match it Dermatologist-supervised protocol on the finished product Signed study report with reaction incidence 4–8 weeks; protocol duration is not compressible
Pilot run and scale-up check Consistency from lab to production Compare pH, viscosity, odor, and fill weight against the lab standard Full QC on the pilot batch before release Pilot batch record and QC comparison table 2–4 weeks; catches viscosity drift before money is spent
Documentation handoff Audit readiness and retailer onboarding Make the evidence pack a release condition, not a follow-up request COA, SDS, stability, micro, and GMP certificate complete at release Controlled document index with revision numbers 1–2 weeks; prevents post-launch document chasing

7. FAQ

Is “unscented” the same as “fragrance-free”?

No. In common U.S. retail usage, “unscented” often signals that no scent was added for a fragrance effect, and it may still involve a masking ingredient used to cover base odor. “Fragrance-free” is generally read as excluding fragrance materials altogether — which is why the term needs a written definition, a full ingredient screen, and sign-off before it appears on pack.

Can we claim fragrance-free if we only used essential oils?

Not automatically. Essential oils, aromatic botanical extracts, masking agents, and functional ingredients with a strong inherent odor all need to be evaluated against your target market and your brand claim standard. The safe operating rule is to claim only after ingredient and market review, with the review documented.

Do we need to declare individual fragrance allergens in the U.S.?

It depends on your retailer and on any state-level ingredient disclosure requirements that apply to you. If you also sell in the EU or Canada, specific fragrance allergens must be listed individually once they exceed the applicable threshold — “Parfum” or “fragrance” alone is not sufficient there. Build the declaration capability into your formula records from the start so you are not retrofitting labels market by market.

Does one patch test support a “hypoallergenic” claim?

Generally not on its own. A patch test result is one input; hypoallergenic positioning needs an evidence package aligned to the market’s expectations and to the exact wording you plan to use. Decide the claim first, then design and review the protocol against it.

Can we say “chemical-free” or “natural” on a moisturizer?

“Chemical-free” is technically inaccurate for a formulated cosmetic and risks misleading consumers; it is best avoided. “Natural” and “clean” are not legal safety grades and should not imply that a product is inherently safer. If you use these terms, they need the same claim-matrix treatment as any other on-pack statement.

Next step

Send your claim intent, target market, SKU list and formats, positioning, packaging direction, and launch date in one message — that combination is what shortens a quote from days to hours, because it lets the formula and documentation scope be priced together rather than discovered in sequence.

Request a Quote

Hi, I'm your LAEYO representative, hope you like this blog post.

With more than 20 years of experience in OEM/ODM/Private Label Cosmetics, I'd love to share valuable knowledge related to cosmetics & skincare products from a top-tier Chinese supplier's perspective.

  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).